OR WAIT null SECS
December 04, 2023
Critical factors need to be addressed for pharma stakeholders to realize the full potential of generative artificial intelligence.
November 01, 2023
Exagamglogene autotemcel (exa-cel) has shown the potential to be a landmark therapy in preventing episodes of excruciating pain among patients with sickle cell disease.